US: YouTube adds competition with new Gaming Service
June 14, 2015
No Comments
YouTube Gamin, Google’s attempt at game streaming market is set to launch. This video game-based initiative is YouTube’s answer to
CPI
Antitrust Developments in Food and Pharma
June 14, 2015
No Comments
Posted by Social Science Research Network Antitrust Developments in Food and Pharma John M. Connor (Purdue University) Abstract: Closing the
Teaching Antitrust Online
June 12, 2015
No Comments
This article is part of a Chronicle. See more from this Chronicle Max Huffman, Jun 12, 2015 Antitrust is enjoying
South Korea: Elliott Associates creates another roadblock for Samsung C&T merger
June 11, 2015
No Comments
Elliott Associates, the third-largest shareholder in Samsung C&T has filed an injunction to block a proposed $8bn merger of Samsung
UK: Greene King gets green light for takeover of Spirit
June 11, 2015
No Comments
Greene King has cleared the way to complete its £774 million takeover of rival pub empire Spirit by saying it
UK: Ofcom to make it easier to quit slow broadband providers
June 11, 2015
No Comments
The broadband industry’s watchdog has announced it will make it easier for customers to leave broadband contracts if their speeds
Australia: ACCC probing iiNet deal over lack of competition
June 11, 2015
No Comments
The Australian Competition and Consumer Commission is investigating if TPG Telecom’s proposed acquisition of iiNet would substantially lessen competition in
UK: Ryanair lawyers to appeal “ridiculous” regulator ruling
June 11, 2015
No Comments
The UK competition commission has ordered Ryanair to sell most of its almost 30% stake in Aer Lingus. The final
EU: Acquisition of ADM US $1.3 billion cocoa business by Olam
June 11, 2015
No Comments
The European Commission said on Thursday it had approved the acquisition of Archer Daniels Midland Co’s cocoa business by Olam
India: Competition body cracks down on GSK
June 11, 2015
No Comments
Citing an anticompetitive agreement that was “clearly made out,” India’s Competition Commission took issue with GlaxoSmithKline and Sanofi’s operations in
